Richard T Hume

Director Richard T Hume sells 5,000 shares ($1.4M) at SNX under pre-arranged 10b5-1 plan

Richard T Hume, a director, executed 11 separate sales totaling 5,000 shares for $1,401,893.63 on 2026-06-02 under a 10b5-1 trading plan adopted on 2026-02-02, reducing his stake from 28,537 shares to 23,537 shares. This is a scheduled, non-discretionary transaction, so the sale timing reflects plan mechanics rather than director judgment. His prior trades at SNX show 30-day returns ranging from +20.4% to +22.6%, suggesting his past exit points at this ticker have historically been followed by continued stock appreciation. The current stock price of $279.25 sits -2.4% from the 52-week high of $286.25, while the 30-day and 90-day changes are +22.6% and +76.7% respectively, indicating the stock has rallied substantially in recent periods.

Director Richard T Hume executes 6 scheduled sales totaling 5,000 shares at SNX via 10b5-1 plan; retains 28,537 shares.

Richard T Hume sold 5,000 shares across 6 separate transactions on 2026-05-18, with prices ranging from $227.93 to $232.07 and a blended average of $229.54, for a total of $1,147,691.83. This sale reduces his holdings from 33,537 shares to 28,537 shares (-14.9% net change). The transaction is part of a pre-arranged 10b5-1 trading plan adopted 2026-02-02, meaning the sales were scheduled and not discretionary. At current price of $227.88, the stock trades -6.0% from its 52-week high of $242.49 and +6.3% over the past 30 days. Hume's prior sales at SNX (5 trades on 2026-05-05) showed modest negative 30-day and 90-day returns, though his cross-ticker track record showed average 90-day returns of +23.6% following prior sales, indicating mixed timing signals across his broader transaction history.

Director Richard T. Hume sells 5,000 SNX shares for $1.17M; repeat seller shows conflicting short- vs. long-term timing on prior trades.

Richard T. Hume, a director at TD SYNNEX, sold 5,000 shares on a single trading day for approximately $1.17 million, representing his tenth open-market sale at this company over the past three years. The stock is trading below its 52-week high but has rallied significantly over recent months on improving fundamentals—the company is profitable with growing revenue. Hume's five prior sales at SNX present a mixed timing picture: all five were well-timed at the 30-day horizon, meaning the stock did not rise further in the immediate aftermath, but all five proved poorly timed over the longer 90-day window as shares recovered and advanced substantially. This conflicting pattern—early timing that looked correct versus delayed outcomes that questioned the exit—repeats in his current sale. As a director with modest holdings, Hume continues a consistent pattern of open-market sales rather than purchases, adding to his track record of exits across his entire portfolio over the three-year filing window.

Director Richard T Hume sold 23,365 shares ($3.8M) at TD SYNNEX SNX on 2026-02-02; post-sale holdings 42,515 shares.

Richard T Hume, a director of TD SYNNEX, executed 5 separate sales totaling 23,365 shares for $3,753,016.61 on 2026-02-02, reducing his holdings by -35.5% from 65,880 to 42,515 shares. The sales occurred at prices ranging from $157.66 to $161.18, with a blended average of $160.63, while the current price stands at $164.39 (near the 52-week high of $166.01). His prior sales at this ticker show 0 of 1 measurable outcomes as well-timed, with his last SNX sale on 2025-06-27 followed by a +19.3% 90-day gain—a poorly timed exit. The company maintains solid fundamentals with $15.7B revenue, +6.9% annual growth, and a P/E of 14.55, offering limited fundamental red flags to explain the substantial position reduction.

Director Hume sold 38.0K shares ($6.1M) at $160.56 average, reducing stake 44.4%; prior SNX sells consistently failed to precede declines.

Richard T Hume, a director at TD SYNNEX, executed 4 separate sales totaling 37,991 shares for $6,099,711.70 across two trading days (2026-01-28 to 2026-01-29) at a blended average price of $160.56, reducing his holdings by -44.4% from 85,506 shares to 47,515 shares. His five prior sales at SNX (all conducted on 2025-06-27) each showed positive 30-day and 90-day returns, meaning the stock rose after every prior sale; the timing pattern shows 0 of 5 prior sells were well-timed (a well-timed sell would have preceded a decline). The current stock price of $158.67 is -4.4% from the 52-week high of $166.01, and the stock has advanced +5.6% over the past 30 days. The company trades at a P/E of 14.04 with $15.7B in latest quarterly revenue and annual revenue growth of +6.9%.

Director Richard T. Hume sells 63,310 shares ($8.6M) across 6 transactions; prior SNX trades show 5 of 5 well-timed sells

Director Richard T. Hume executed 6 separate sales totaling 63,310 shares for $8,624,466.77 on 2025-06-27, reducing his SNX holdings from 130,825 shares to 67,515 shares (-48.4%). The blended average sale price of $136.23 falls near the current price of $135.70, within the 52-week range of $95.81–$144.69 and -6.2% from the 52-week high. The critical signal lies in Hume's prior trading pattern at SNX: his 5 previous sales, all executed on 2025-03-03, each showed negative 90-day returns ranging from -9.4% to -12.2%, indicating they were well-timed ahead of subsequent price declines. This 5-of-5 track record of well-timed sells at this specific ticker stands apart from his cross-ticker history (20 prior sells with 65% well-timed rate). While this sale occurs near recent highs within the broader uptrend (90-day change: +30.7%), the demonstrated pattern of ahead-of-the-move exits at SNX warrants tracking whether this substantial reduction repeats that predictive behavior.

Director Richard T Hume sold 20.0K shares of TD SYNNEX (SNX) for $2.7M on 2025-03-03 at blended avg $135.88.

Richard T Hume, a director at TD SYNNEX, executed 6 separate sales totaling 20,000 shares on 2025-03-03 for $2,717,603.07, reducing his holdings by -23.4% to 65,480 shares post-transaction. The sales were priced between $133.95 and $138.15, with a blended average price of $135.88, which is currently above the stock's present price of $132.20 (trading at -8.6% from the 52-week high of $144.69). His cross-ticker track record shows 20 prior sells with a 90d well-timed rate of 15.38%, but at SNX specifically, he has 5 prior trades with zero measurable outcomes on timing (all recent, within the past two months), limiting the ability to assess pattern at this ticker. The company's fundamentals show $14.7B in quarterly revenue with a P/E of 15.04 and annual revenue growth of +1.6%.

Director Richard Hume sold 20,000 SNX shares for $2,800,183.05 on 2025-02-03; retains 85,480 shares post-sale.

Richard T Hume, a Director at TD SYNNEX CORP, executed 4 separate sales totaling 20,000 shares for $2,800,183.05 on 2025-02-03, reducing his holdings by 19.0% from 105,480 to 85,480 shares. The blended average price of $140.01 comes amid elevated 30-day momentum (+18.7%) and strong 90-day performance (+13.0%), with the stock trading near its 52-week high of $143.19. His cross-ticker selling track record shows a 90-day well-timed rate of 33.33%, while his prior trades at SNX (including three sells on 2025-01-03 showing 20.7%–22.3% 30-day gains) have not yet provided measurable 90-day outcomes. The large-scale disposal, while discrete, occurs on a stock in an uptrend and does not provide clear directional signal absent guidance on whether this disposition relates to planned succession, portfolio rebalancing, or other motivations.

Director Hume sold 20,000 SNX shares for $2.35M (Jan 3), retaining 111,080 shares; stock down 4.0% in 30 days.

Director Richard T. Hume filed 3 separate sales totaling 20,000 shares for $2,352,326.86, reducing his holdings by 15.3% from 131,080 to 111,080 shares. The sales occurred at blended average price $117.62, with the stock currently at $118.30 and down 4.0% over the prior 30 days. His prior trades at SNX (5 sales on 2024-12-02) each showed negative 30-day returns ranging from -1.2% to -3.9%, establishing a pattern of sales followed by near-term weakness. SNX fundamentals show declining annual revenue (-7.7% year-over-year) with modest profitability (P/E of 14.77 and $178.6M net income on $14.7B revenue), and the stock trades 11.0% below its 52-week high of $132.85. The sale represents a material reduction in Hume's direct position but occurs within historical context of his recent selling activity in the same ticker.

Director HUME sold 20,000 shares (13.2% of holdings) for $2.4M on 2024-12-02 at $121.25 blended average

Director Richard T. Hume executed 5 separate sales totaling 20,000 shares for $2,424,984.32 on 2024-12-02, reducing his post-transaction holdings to 131,080 shares from 151,080 shares. The sales occurred across a narrow price range ($118.75–$122.04) with a blended average of $121.25, near the current price of $122.39 and 7.9% below the 52-week high of $132.85. At the company level, SNX faces headwinds: annual revenue declined 7.7% year-over-year, and the stock is up 6.0% over both the 30-day and 90-day periods despite the overall negative earnings trajectory. Across his cross-ticker open-market trade history, Hume's prior sells were well-timed at the 90-day mark in only 28.57% of cases; at SNX specifically, his 5 prior trades (all sells) show mixed near-term results with recent sales on 2024-11-04 and 2024-10-16 that were either unmeasured or slightly negative (−3.8% to −4.8% at 30 days). The magnitude of this sale (13.2% of holdings) represents a meaningful reduction in his position at a time when the company is reporting revenue contraction.